Precigen
PGEN
157 hedge funds and large institutions have $65.1M invested in Precigen in 2023 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 65 increasing their positions, 32 reducing their positions, and 22 closing their positions.
103% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 32
4.04% more ownership
Funds ownership: 20.33% → 24.37% (+4%)
1% more capital invested
Capital invested by funds: $64.2M → $65.1M (+$901K)
2% less funds holding
Funds holding: 161 → 157 (-4)
14% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 22
47% less call options, than puts
Call options by funds: $124K | Put options by funds: $234K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MVP
Miller Value Partners
Sarasota,
Florida
|
+$13.7M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.91M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.61M |
| 4 |
Renaissance Technologies
New York
|
+$2.1M |
| 5 |
BlackRock
New York
|
+$2.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$3.12M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$767K |
| 3 |
Axa
Paris,
France
|
-$627K |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$586K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$353K |
PGEN Hedge Fund Activity: Q1 2023 in Review
157 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q1 2023, worth a combined $65.1M — up 1.4% from $64.2M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of PGEN and 19 opened new positions — a net loss of 3 holders — while 32 trimmed existing stakes and 65 added.
The largest buyer was Miller Value Partners, opening a new position worth an estimated $13.7M. The largest seller was Millennium Management, cutting an estimated $3.12M.
- 157 institutional investors held Precigen (PGEN) as of Q1 2023, down from 161 in Q4 2022.
- Funds reported $65.1M of Precigen stock for Q1 2023, up 1.4% quarter-over-quarter.
- 19 funds opened new Precigen positions in Q1 2023 and 22 closed out, a net change of -3 holders.
- The largest Precigen buyer in Q1 2023 was Miller Value Partners, an estimated $13.7M added.
- The largest Precigen seller in Q1 2023 was Millennium Management, an estimated $3.12M sold.
Based on aggregated 13F filings for Q1 2023.